英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
vectura查看　vectura　在百度字典中的解释百度英翻中〔查看〕
vectura查看　vectura　在Google字典中的解释Google英翻中〔查看〕
vectura查看　vectura　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Inhalation Therapies Expertise | Phillips Medisize - Vectura
    The 2025 Vectura acquisition expanded our capabilities Today, we specialize in innovative inhaled drug development, leveraging more than 25 years of experience to help bring your medicines to market
  • Vectura - Wikipedia
    Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England which develops inhaled medicines and makes inhaler devices It was listed on the London Stock Exchange until it was acquired by Philip Morris International in September 2021
  • Tobacco firm PMI divests Vectura at a loss after backlash
    Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the £1 1 billion ($1 45 billion) it paid for the business three years ago
  • Molex, Phillips Medisize Close Acquisition of Vectura Group
    In a press release on Jan 7, 2025, Phillips Medisize’s parent company, Molex, announced the completion of Phillips Medisize’s acquisition of Vectura Group from Vectura Fertin Pharma, of Chippenham, United Kingdom, a subsidiary of Philip Morris International (1)
  • Phillips Medisize completes Vectura acquisition from Philip Morris
    The company says adding Vectura enables it to offer a wider range of formulation, device design, combination product development and manufacturing services It acquires Vectura’s proprietary technology and combination product development expertise in dry powder inhalers (DPI)
  • Molex Closes Acquisition of Vectura Group | Contract Pharma
    The transaction includes Vectura’s proprietary technology and combination product development expertise in dry powder inhalers (DPI), including the Lever Operated Multi-dose Inhaler (LOMI) and Gyrohaler platforms; metered dose inhalers (MDI); nasal inhalers; and nebulizers, including the FOX device
  • Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire . . .
    Vectura brings to Phillips Medisize its unique inhalation expertise that includes formulation and device development for dry powder inhalers (DPI), pressurized metered dose inhalers (pMDI), nasal and nebulizer products for small molecules, biologics, complex combinations and generic products
  • Phillip Morris sell Vectura after academic freeze-out
    Vectura, a pharmaceutical company that specialises in inhaled medicines for conditions such as chronic obstructive pulmonary disease, was acquired by PMI in September, 2021, after a successful takeover bid that valued the company at £1·1 billion The acquisition was widely condemned
  • Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire . . .
    Vectura brings to Phillips Medisize its unique inhalation expertise that includes formulation and device development for dry powder inhalers (DPI), pressurized metered dose inhalers (pMDI), nasal and nebulizer products for small molecules, biologics, complex combinations and generic products
  • Phillips Medisize parent company Molex completes acquisition of Vectura
    Phillips Medisize announced that its parent company Molex has completed its acquisition of inhalation CDMO Vectura, which was initially announced in September 2024 According to the announcement, the acquisition covers all of Vectura’s assets in addition to its OINDP analysis and development services business, which employs 350 people





中文字典-英文字典  2005-2009